Cargando…

Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation

INTRODUCTION: Discontinuation of tyrosine kinase inhibitor (TKI) treatment is emerging as the main therapy goal for Chronic Myeloid Leukemia (CML) patients. The DESTINY trial showed that TKI dose reduction prior to cessation can lead to an increased number of patients achieving sustained treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karg, Elena, Baldow, Christoph, Zerjatke, Thomas, Clark, Richard E., Roeder, Ingo, Fassoni, Artur C., Glauche, Ingmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769401/ https://www.ncbi.nlm.nih.gov/pubmed/36568156 http://dx.doi.org/10.3389/fonc.2022.1028871

Ejemplares similares

Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data
por: Fassoni, Artur C., et al.
Publicado: (2018)

How to predict relapse in leukemia using time series data: A comparative in silico study
por: Hoffmann, Helene, et al.
Publicado: (2021)

MAGPIE: Simplifying access and execution of computational models in the life sciences
por: Baldow, Christoph, et al.
Publicado: (2017)

Data integration between clinical research and patient care: A framework for context-depending data sharing and in silico predictions
por: Hoffmann, Katja, et al.
Publicado: (2023)

PB1979: DATA INTEGRATION BETWEEN CLINICAL RESEARCH AND PATIENT CARE: A FRAMEWORK FOR CONTEXT-DEPENDING DATA SHARING AND IN SILICO PREDICTIONS
por: Hoffmann, Katja, et al.
Publicado: (2023)

Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia
por: Baldow, Christoph, et al.
Publicado: (2016)

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
por: Volz, Christian, et al.
Publicado: (2023)

Quantitative prediction of long-term molecular response in TKI-treated CML – Lessons from an imatinib versus dasatinib comparison
por: Glauche, Ingmar, et al.
Publicado: (2018)

PB1767: CHALLENGES IN MACHINE LEARNING-BASED DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Thielecke, Lars, et al.
Publicado: (2023)

Nanog Variability and Pluripotency Regulation of Embryonic Stem Cells - Insights from a Mathematical Model Analysis
por: Glauche, Ingmar, et al.
Publicado: (2010)

A Model-Based Analysis of Culture-Dependent Phenotypes of mESCs
por: Herberg, Maria, et al.
Publicado: (2014)

Clonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion
por: Cornils, Kerstin, et al.
Publicado: (2017)

Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo
por: Wagner, Sebastian, et al.
Publicado: (2022)

Imaging, quantification and visualization of spatio-temporal patterning in mESC colonies under different culture conditions
por: Scherf, N., et al.
Publicado: (2012)

Stem Cell Proliferation and Quiescence—Two Sides of the Same Coin
por: Glauche, Ingmar, et al.
Publicado: (2009)

Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology
por: Hoffmann, Katja, et al.
Publicado: (2020)

Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
por: Dobrowolski, Jerome, et al.
Publicado: (2019)

A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase
por: Kirova, Dilyana Georgieva, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Mathematical Modeling of Oncogenesis Control in Mature T-Cell Populations
por: Gerdes, Sebastian, et al.
Publicado: (2013)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Comparative Gene Expression Analysis Reveals Similarities and Differences of Chronic Myeloid Leukemia Phases
por: Schwarz, Annemarie, et al.
Publicado: (2022)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Quantitative Cell Cycle Analysis Based on an Endogenous All-in-One Reporter for Cell Tracking and Classification
por: Zerjatke, Thomas, et al.
Publicado: (2017)

Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
por: Arriazu, Elena, et al.
Publicado: (2016)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
por: Pulikkan, John Anto, et al.
Publicado: (2018)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Acute Myeloid Leukemia as a Model for Cancer Therapy
por: Ravandi, Farhad
Publicado: (2012)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
por: Ottone, Tiziana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1qkq3kf4i412mm0vuv3k62gd7